No Data
No Data
Express News | Hinova Pharmaceuticals Says Shareholder to Unload up to 2% Stake in Three Months
Hinova Pharmaceuticals Inc.'s (SHSE:688302) Market Cap Touched CN¥4.3b Last Week, Benefiting Both Individual Investors Who Own 43% as Well as Institutions
2025 First Quarter Report
Haichuang Pharmaceutical Co., Ltd. 2024 Annual Report
2024 Annual Report Summary
Haichuang Pharmaceutical (688302.SH) announced its 2024 annual performance, with a net loss attributable to the parent company of 0.199 billion yuan, a reduced loss.
Haichuang Pharmaceutical (688302.SH) released its annual report for 2024, with the company's revenue for the year 2024 at 36...